Five-year-old Hello Kitty fan Berkley received a surprise outside of her window during treatment for neuroblastoma.
A neuroblastoma is a malignant tumor that most frequently occurs in children under five years of age. It is the most common malignant abdominal tumor seen in children.
The solid tumor cancer program at Children's is one of the largest of its kind in the Upper Midwest. We diagnose and treat children with all types of solid tumors, including the following:
A brain and spinal cord tumor, also known as a central nervous system (CNS) tumor, is an abnormal growth that occurs in any part of the brain or spinal cord. CNS tumors are the second most common pediatric cancer, after leukemia, and the most common solid tumor of childhood. The cause of most CNS tumors is unknown. Brain tumors are not contagious, and nothing you have done or not done is responsible for your child's tumor.
Aili Kleven was diagnosed with stage 3 intermediate-risk neuroblastoma.
Patient and Family Education Materials If you need quick, clear info about a kids' health topic, we have it all!
The cancer and blood disorders team at Children's Minnesota has the training, knowledge and technology to treat a wide range of conditions. Nearly 900 children are admitted annually as inpatients to the Jim and Colleen Ryan Pediatric Cancer and Blood Disorders Center at Children's – Minneapolis, making us the largest program in the Upper Midwest. And while we're known as a leader and innovator in the field of pediatric cancer and blood disorder treatment, we never forget that each patient is someone's child. Compassion always factors into our approach. We are on the journey with you, because we believe that better journeys lead to better outcomes.
It can be frightening to hear that a child has cancer or a blood disorder. At Children's Minnesota, we're experts in treating the disease and supporting the patient and family. In addition to offering advanced, individualized care for newly diagnosed children, teens and young adults with cancers and blood disorders, we also provide innovative treatment for rare, relapsed and recurrent cancers.